戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 with a complex phenotype that includes renal salt wasting.
2  antidiuretic hormone secretion and cerebral salt wasting.
3 sh these possibilities, focusing on cerebral salt wasting.
4  antidiuretic hormone secretion and cerebral salt wasting.
5 rientation and cleavage of ENaC, despite the salt wasting.
6 /Cl(-) cotransporter (NCC) manifest profound salt wasting.
7             Presentations vary from neonatal salt wasting and atypical genitalia, to adult presentati
8 w a similar phenotype to Bartter syndrome of salt wasting and dehydration due to reduced Na-K-2Cl-cot
9 nversely, low circulating aldosterone causes salt wasting and hypotension.
10                                           In salt wasting and nonclassical CAH, a phenotype can be at
11  Pendrin/NCC double KO mice displayed severe salt wasting and sharp increase in urine output under ba
12 uncommon inherited disorder characterized by salt-wasting and end-organ unresponsiveness to mineraloc
13 us died; the other two had transient massive salt-wasting and polyuria reminiscent of antenatal Bartt
14 th kinases would lead to polyuria and severe salt-wasting, and generated SPAK/OSR1 double knockout mi
15 lls and with purified enzymes differed among salt-wasting- and nonclassical-associated variants, but
16 ting both kinases causes severe polyuria and salt-wasting by generating SPAK/OSR1 double knockout (DK
17                 A total of 143 patients with salt-wasting CAH were identified; none were missed.
18             Sensitivity of the screening for salt-wasting CAH.
19 mprove the growth of children with polyuric, salt-wasting CRI.
20                            The term cerebral salt wasting (CSW) was introduced before the syndrome of
21  mutations to these subunits can lead to the salt wasting disease pseudohypoaldosteronism type I, ass
22 hannel defective in gating that leads to the salt-wasting disease pseudohypoaldosteronism type I, was
23  CYP21A2 cause complete loss of function and salt-wasting disease.
24 ected diagnosis of Bartter syndrome, a renal salt-wasting disease.
25 th chronic renal failure caused by polyuric, salt-wasting diseases may be hampered if ongoing sodium
26 utations in hENaC result in hypertensive and salt-wasting diseases.
27 give rise to Gitelman syndrome, a hereditary salt-wasting disorder thought in most cases to arise fro
28 hydroxylase deficiency (25 children with the salt-wasting form and 13 with the simple virilizing form
29 or CAH was highly effective in detecting the salt-wasting form and thereby reducing mortality.
30 yperplasia (CAH) owing to low sensitivity in salt-wasting forms and a high rate of recall (ie, a posi
31             Aldosterone synthase deficiency, salt-wasting forms of congenital adrenal hyperplasia, an
32 erited hypokalaemic alkalosis resulting from salt-wasting has proved fertile ground for identificatio
33 zed by renal resistance to aldosterone, with salt wasting, hyperkalemia, and metabolic acidosis.
34 orption, cause Bartter's syndrome, featuring salt wasting, hypokalaemic alkalosis, hypercalciuria and
35 ds out since the CA12(E143K) mutation causes salt wasting in sweat and dehydration in humans.
36         Recent studies suggest that cerebral salt wasting is a rare cause of hyponatremia.
37                                When cerebral salt wasting is diagnosed, it is often difficult to make
38 e kidney-specific MR-knockout mice exhibited salt wasting, low BP, and hyperkalemia.
39 tion of Kir4.1 in these mice led to moderate salt wasting, low BP, and profound potassium wasting.
40 characterized by hypokalaemic alkalosis with salt-wasting, low blood pressure, normal magnesium and h
41  channel cause Bartter's disease, a familial salt wasting nephropathy.
42 hypomagnesaemia, hypocalciuria and displayed salt wasting on switching to a low-Na diet.
43 le deletion of pendrin or NCC does not cause salt wasting or excessive diuresis under basal condition
44 ve P450 21A2 variants associated with either salt-wasting or nonclassical forms of CAH were expressed
45 tations can be associated either with severe salt-wasting or simple virilizing phenotypes or with mil
46  CaR mutations with a Bartter syndrome-like, salt-wasting phenotype, but the precise mechanism for th
47 with one of three known forms of CAH, namely salt wasting, simple virilizing, or nonclassical CAH.
48             The word 'cerebral' in 'cerebral salt wasting syndrome' can thus be inappropriate, convey
49 oss-of-function mutations of NCC cause renal salt wasting with arterial hypotension (Gitelman syndrom
50  I (PHA1) is characterized by neonatal renal salt wasting with dehydration, hypotension, hyperkalaemi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。